東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Cancer biomarkers in body fluids = p...

Dakubo, Gabriel D.

FindBook

Google Book

Amazon

博客來

Cancer biomarkers in body fluids = principles /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Cancer biomarkers in body fluids/ by Gabriel D. Dakubo.
其他題名:	principles /
作者:	Dakubo, Gabriel D.
出版者:	Cham :Springer International Publishing : : 2016.,
面頁冊數:	xvi, 299 p. :ill., digital ;24 cm.
Contained By:	Springer eBooks
標題:	Cancer - Genetic aspects. -
電子資源:	http://dx.doi.org/10.1007/978-3-319-01580-4
ISBN:	9783319015804$q(electronic bk.)

Cancer biomarkers in body fluids = principles /
Dakubo, Gabriel D.

Cancer biomarkers in body fluidsprinciples /[electronic resource] :by Gabriel D. Dakubo. - Cham :Springer International Publishing :2016. - xvi, 299 p. :ill., digital ;24 cm.

The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.

ISBN: 9783319015804$q(electronic bk.)

Standard No.: 10.1007/978-3-319-01580-4doiSubjects--Topical Terms:

669248
Cancer
--Genetic aspects.

LC Class. No.: RC270

Dewey Class. No.: 616.9940756

Cancer biomarkers in body fluids = principles /
LDR:02545nmm a2200301 a 4500 001 2052452
003 DE-He213
005 20160901122758.0
006 m d
007 cr nn 008maaau
008 170421s2016 gw s 0 eng d
020 $a 9783319015804$q(electronic bk.)
020 $a 9783319015798$q(paper)
024 7 $a 10.1007/978-3-319-01580-4 $2 doi
035 $a 978-3-319-01580-4
040 $a GP $c GP
041 0 $a eng
050 4 $a RC270
072 7 $a MFN $2 bicssc
072 7 $a MED107000 $2 bisacsh
082 0 4 $a 616.9940756 $2 23
090 $a RC270 $b .D135 2016
100 1 $a Dakubo, Gabriel D. $3 1067297
245 1 0 $a Cancer biomarkers in body fluids $h [electronic resource] : $b principles / $c by Gabriel D. Dakubo.
260 $a Cham : $b Springer International Publishing : $b Imprint: Springer, $c 2016.
300 $a xvi, 299 p. : $b ill., digital ; $c 24 cm.
520 $a The molecular and genetic signatures of cancer are represented in the peripheral circulation and other body fluids, giving rise to the "liquid biopsy" concept. This new paradigm of molecular profiling of cancer cells offers several advantages over traditional tissue biopsy. It is convenient, noninvasive, conforms to current clinical practice, enables real time disease monitoring and the study of tumor evolution, can easily be sampled multiple times, and this sample is more representative of the heterogeneous cancer cells than biopsy sampling. Indeed, all aspects of cancer molecular genetic information, stemming from DNA (both nuclear and mitochondria), RNA (coding and noncoding), peptides and proteins, metabolites and lipids are present in body fluids as free, cell surface bound or enclosed in membrane vesicles, and are being harnessed for disease management. Additionally, circulating tumor, and tumor stem cells provide prognostic information, and also enable the study of the intricate molecular processes associated with metastasis and drug resistance. This treatise deals with the general principles of the molecular pathology of cancer, and its associated imprints in circulation. The transitional process from discovery, prototype development, translational research, to product development can be complex and costly. The critical path to biomarker development and qualification for successful use in drug development is detailed herein as well. This book is of interest to Cancer Researchers, Oncologists, Clinicians, Surgeons, Medical Students, Nurses, Diagnostic Laboratories, and Pharmaceutical Industries.
650 0 $a Cancer $x Genetic aspects. $3 669248
650 0 $a Biochemical markers. $3 587592
650 0 $a Cancer $x Molecular diagnosis. $3 669887
650 1 4 $a Biomedicine. $3 890831
650 2 4 $a Human Genetics. $3 891169
650 2 4 $a Oncology. $3 751006
650 2 4 $a Cancer Research. $3 891172
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
856 4 0 $u http://dx.doi.org/10.1007/978-3-319-01580-4
950 $a Biomedical and Life Sciences (Springer-11642)